Status:
NOT_YET_RECRUITING
Effect of Cross-linked Hyaluronic Acid Filler Versus Botulinum Toxin Type A (Botox) in Management of Gummy Smile
Lead Sponsor:
Cairo University
Conditions:
Gummy Smile Due to Hypermobile Upper Lip
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
A smile is supposed to express one's feelings and expressions, for that there has been an awakening concern for the appearance of gummy smile. Gummy smile is the appearance of about 2mm or more of the...
Detailed Description
In patients not preferring surgical correction of gummy smile, botulinum toxin injection type A can be a helpful solution for reduction of peri-oral muscular hypermobility. A characteristic feature of...
Eligibility Criteria
Inclusion
- Patients with excessive gingival display ranging from 3-8mm due to hypermobile lip.
- Age ranges from 18 years or above.
Exclusion
- Excessive gingival display due to other etiological factors.
- Patients allergic to botox or hyaluronic acid fillers.
- Patients with any medical condition that contraindicates botox or hyaluronic acid filler injection.
- Patients previously injected with permanent fillers.
- Pregnancy.
- Breastfeeding females.
- Patients with active inflammatory or infectious disease at intended site of injection.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06952218
Start Date
December 1 2025
End Date
December 1 2025
Last Update
April 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CairoU
Cairo, Egypt, 00200
2
Cairo University
Giza, Egypt, 12613